TITLE:
Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CONDITION:
COPD

INTERVENTION:
QAB149

SUMMARY:

      The trial is designed to identify an appropriate dose of QAB149 for delivery via a multiple
      dose inhaler for use in the COPD Phase III program.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 40 Years to 75 Years
Criteria:

        Inclusion Criteria:

          -  Diagnosis of COPD

          -  Age 40-75 years

          -  Smoking history

        Exclusion Criteria:

          -  Other serious disease

          -  Allergy to QAB149

          -  Respiratory tract infection
      
